FDA Approved.
FDA Approved.
A visionary company
Transforming ophthalmic care with sustained release therapies
Hydrogel Technology
A platform Engineered for Ocular Innovation
Driven by a vision
Pioneering a new era of drug delivery in ophthalmology
Ocular Therapeutix is a biopharmaceutical platform company leveraging its formulation expertise to develop transformational drug treatments that enhance people’s lives.
Featured Press Release
Topline results of P3 trial of DEXTENZA for the treatment of alergic conjunctivitis